Latest Chemotherapy news
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
posted September 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer
posted September 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
posted September 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Suicide Risk Higher for Cancer Patients Not Proceeding With Recommended Surgery
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors 
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Cancer Drug Shortages Persist at All Cancer Centers 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Monthly Specialist Briefings
Stay Connected
